Literature DB >> 15003812

A variant of childhood-onset myasthenia gravis: HLA typing and clinical characteristics in Japan.

Noriaki Shinomiya1, Yoshiko Nomura, Masaya Segawa.   

Abstract

To investigate the correlation between clinical features and HLA DR/DQ genetic variability in myasthenia gravis (MG), we evaluated HLA DR/DQ allele frequencies in 87 Japanese patients with childhood-onset disease. HLA genotypes DRB1*1302/DQA1*0102/DQB1*0604 and DRB1*0901/DQA1*0301/DQB1*0303 were significantly higher in patients than in healthy controls (P(c) < 0.0001, RR = 5.5; P(c) < 0.0001, RR = 8.5, for two genotypes, respectively). Patients who had a significantly higher likelihood of the HLA types DRB1*1302/DQA1*0102/DQB1*0604 or DRB1*0901/DQA1*0301/DQB1*0303 belonged to the latent general type (LG) of MG; this is clinically ocular type, but shows myasthenic electromyographic findings in extremity muscles. The LG type of MG was observed in 78% of patients exhibiting the clinically ocular type; this group comprised approximately 75% of patients with childhood-onset MG. These date suggest that LG type of MG may present a particular subset of childhood-onset MG, which is associated with the specific HLA subtypes DRB1*1302/DQA1*0102/DQB1*0604 and DRB1*0901/DQA1*0301/DQB1*0303.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15003812     DOI: 10.1016/j.clim.2003.10.004

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  10 in total

1.  Characteristics of late-onset myasthenia gravis.

Authors:  Saša A Zivković; Paula R Clemens; David Lacomis
Journal:  J Neurol       Date:  2012-04-05       Impact factor: 4.849

2.  Clinical and serological study of myasthenia gravis in HuBei Province, China.

Authors:  Xiaofan Zhang; Mingshan Yang; Jinzhi Xu; Min Zhang; Bethan Lang; Wei Wang; Angela Vincent
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-06       Impact factor: 10.154

3.  The HLA-B*4601-DRB1*0901 haplotype is positively correlated with juvenile ocular myasthenia gravis in a southern Chinese Han population.

Authors:  Hui-Yu Feng; Li-Xuan Yang; Wei-Bin Liu; Xin Huang; Li Qiu; Yan Li
Journal:  Neurol Sci       Date:  2015-05-08       Impact factor: 3.307

4.  Clinical characteristics and therapeutic evaluation of childhood myasthenia gravis.

Authors:  Zhi-Xiao Yang; Kai-Li Xu; Hui Xiong
Journal:  Exp Ther Med       Date:  2015-02-03       Impact factor: 2.447

5.  Juvenile myasthenia gravis in Norway: HLA-DRB1*04:04 is positively associated with prepubertal onset.

Authors:  T H Popperud; M K Viken; E Kerty; B A Lie
Journal:  PLoS One       Date:  2017-10-16       Impact factor: 3.240

Review 6.  Associations between HLA and autoimmune neurological diseases with autoantibodies.

Authors:  Sergio Muñiz-Castrillo; Alberto Vogrig; Jérôme Honnorat
Journal:  Auto Immun Highlights       Date:  2020-01-22

Review 7.  The Epidemiology and Phenotypes of Ocular Manifestations in Childhood and Juvenile Myasthenia Gravis: A Review.

Authors:  Jeannine M Heckmann; Tarin A Europa; Aayesha J Soni; Melissa Nel
Journal:  Front Neurol       Date:  2022-02-23       Impact factor: 4.003

8.  CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chinese population.

Authors:  Liang Sun; Yunxiao Meng; Yanchen Xie; Hua Zhang; Zheng Zhang; Xiaoxia Wang; Bin Jiang; Wei Li; Yao Li; Ze Yang
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

9.  Molecular and clinical relationship between live-attenuated Japanese encephalitis vaccination and childhood onset myasthenia gravis.

Authors:  Dan He; Han Zhang; Jun Xiao; Xiaofan Zhang; Minjie Xie; Dengji Pan; Minghuan Wang; Xiang Luo; Bitao Bu; Min Zhang; Wei Wang
Journal:  Ann Neurol       Date:  2018-09       Impact factor: 10.422

10.  Human Leukocyte Antigen (HLA) Subtype-Dependent Development of Myasthenia Gravis, Type-1 Diabetes Mellitus, and Hashimoto Disease: A Case Report of Autoimmune Polyendocrine Syndrome Type 3.

Authors:  Mizuki Gobaru; Kenji Ashida; Satoko Yoshinobu; Ayako Nagayama; Masaharu Kabashima; Shimpei Iwata; Nao Hasuzawa; Munehisa Tsuruta; Nobuhiko Wada; Hitomi Nakayama; Seiichi Motomura; Yuji Tajiri; Masatoshi Nomura
Journal:  Am J Case Rep       Date:  2019-11-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.